This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2016 Oct 1;18(suppl_5):v1-v75.

doi: 10.1093/neuonc/now207.

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013

Quinn T Ostrom^{1

2}, Haley Gittleman^{1

2}, Jordan Xu³, Courtney Kromer⁴, Yingli Wolinsky^{1

2}, Carol Kruchko⁵, Jill S Barnholtz-Sloan^{1

2}

Affiliations

Affiliations

¹ Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH USA.
² Central Brain Tumor Registry of the United States, Hinsdale, IL USA.
³ Case Western Reserve University School of Medicine , Cleveland, OHUSA.
⁴ Northeast Ohio Medical University , Rootstown, OHUSA.
⁵ Central Brain Tumor Registry of the United States , Hinsdale, ILUSA.

PMID: 28475809
PMCID: PMC8483569
DOI: 10.1093/neuonc/now207

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013

Quinn T Ostrom et al. Neuro Oncol. 2016.

. 2016 Oct 1;18(suppl_5):v1-v75.

doi: 10.1093/neuonc/now207.

Authors

Quinn T Ostrom^{1

2}, Haley Gittleman^{1

2}, Jordan Xu³, Courtney Kromer⁴, Yingli Wolinsky^{1

2}, Carol Kruchko⁵, Jill S Barnholtz-Sloan^{1

2}

Affiliations

¹ Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH USA.
² Central Brain Tumor Registry of the United States, Hinsdale, IL USA.
³ Case Western Reserve University School of Medicine , Cleveland, OHUSA.
⁴ Northeast Ohio Medical University , Rootstown, OHUSA.
⁵ Central Brain Tumor Registry of the United States , Hinsdale, ILUSA.

PMID: 28475809
PMCID: PMC8483569
DOI: 10.1093/neuonc/now207

No abstract available

PubMed Disclaimer

Figures

Fig. 1. — Fig. 1.
Schematic of Cancer Registration Process for CBTRUS Reporting.

Fig. 2. — Fig. 2.
Average Annual Age-Adjusted Incidence Rates^a of All Primary Brain and Other CNS Tumors in Comparison to Other Common Cancers for A) Children Age 0-14 Years, B) Adolescents and Young Adults Age 15-39 Years, and C) Older Adults Age 40+ Years, CBTRUS Statistical Report: NPCR and SEER 2009-2013, USCS, 2009-2013.

Fig. 3. — Fig. 3.
Average Annual Age-Adjusted Mortality Rates of All Primary Brain and Other CNS Tumors in Comparison to Other Common Cancers and Top Three Non-Cancer Causes of Death for A) Children Age 0-14 Years, B) Adolescents and Young Adults Age 15-39 Years, and C) Older Adults Age 40+ Years, CBTRUS Statistical Report: NVSS^a, 2009-2013.

Fig. 4. — Fig. 4.
Distribution^a of Primary Brain and Other CNS Tumors by Behavior (N=368,117), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 5. — Fig. 5.
Average Annual Age-Adjusted Incidence Rates^a of Primary Brain and Other CNS Tumors by Age and Behavior, CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 6. — Fig. 6.
Annual Age-Adjusted Incidence Rates^a of Primary Brain and Other CNS Tumors by Year and Behavior, CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 7a. — Fig. 7a.
Average Annual Age-Adjusted Incidence Rates^a of Malignant Primary Brain and Other CNS Tumors by Central Cancer Registry, CBTRUS Statistical Report: NPCR and SEER, 2009-2013^b.

Fig. 7b. — Fig. 7b.
Average Annual Age-Adjusted Incidence Rates^a of Non-Malignant Primary Brain and Other CNS Tumors by Central Cancer Registry, CBTRUS Statistical Report: NPCR and SEER, 2009-2013^b.

Fig. 8a. — Fig. 8a.
Distribution^a of All Primary Brain and Other CNS Tumors by Site (N=368,117), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 8b. — Fig. 8b.
Distribution^a of Malignant Primary Brain and Other CNS Tumors by Site (N=117,906), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 8c. — Fig. 8c.
Distribution^a of Non-Malignant Primary Brain and Other CNS Tumors by Site (N=250,211), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 9a. — Fig. 9a.
Distribution^a of All Primary Brain and Other CNS Tumors by CBTRUS Histology Groupings and Histology (N=368,117), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 9b. — Fig. 9b.
Distribution^a of Malignant Primary Brain and Other CNS Tumors by CBTRUS Histology Groupings and Histology (N=117,906), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 9c. — Fig. 9c.
Distribution^a of Non-Malignant Primary Brain and Other CNS Tumors by CBTRUS Histology Groupings and Histology (N=250,211), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 10. — Fig. 10.
Distribution^a of Primary Brain and Other CNS Gliomas^b by Histology Subtypes (N=99,165), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 11. — Fig. 11.
Distribution of Primary Brain and Other CNS Gliomas^a by Site (N=99,165), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 12. — Fig. 12.
Incidence Rate Ratios by Sex (Males:Females) for Selected CBTRUS Histology Groupings and Histology, CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 13. — Fig. 13.
Incidence Rate Ratios by Race (Whites:Blacks) for Selected CBTRUS Histology Groupings and Histologies, CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 14. — Fig. 14.
Age-Adjusted Incidence Rates^a of Brain and Other CNS Tumors by Selected Histologies and Age Groups (Age 20+ Years), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 15. — Fig. 15.
Age-Adjusted Incidence Rates^a in Children and Adolescents of Brain and Other CNS Tumors by Selected Histologies and Age Groups (Age 0-19 Years), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 16a. — Fig. 16a.
Distribution^a in Children and Adolescents (Age 0-19 Years) of Primary Brain and CNS Tumors by Site (N=23,522), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 16b. — Fig. 16b.
Distribution^a in Children and Adolescents (Age 0-19 Years) of Primary Brain and Other CNS Tumors by CBTRUS Histology Groupings and Histology (N=23,522), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 17a. — Fig. 17a.
Distribution^a in Children (Age 0-14 Years) of Primary Brain and Other CNS Tumors by Site (N=16,653), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 17b. — Fig. 17b.
Distribution^a in Children (Age 0-14 Years) of Primary Brain and Other CNS Tumors by CBTRUS Histology Groupings and Histology (N=16,653), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 18a. — Fig. 18a.
Distribution^a in Adolescents^b (Age 15-19 Years) of Primary Brain and Other CNS Tumors by Site (N=6,869), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 18b. — Fig. 18b.
Distribution^a in Adolescents (Age 15-19 Years) of Primary Brain and Other CNS Tumors by Histology (N=6,869), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 19. — Fig. 19.
Average Annual Age-Adjusted Mortality Rates^a for Malignant Primary Brain and Other CNS Tumors by Central Cancer Registry, CBTRUS Statistical Report: NCHS, 2009-2013.

Fig. 20a. — Fig. 20a.
Distribution^a of Primary Spinal Cord, Spinal Meninges, and Cauda Equina Tumors in Children and Adolescents (Age 0-19 Years), CBTRUS Histology Groupings and Histology (N=1,307), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 20b. — Fig. 20b.
Distribution^a of Primary Spinal Cord, Spinal Meninges, and Cauda Equina Tumors in Adults (Age 20+ Years), CBTRUS Histology Groupings and Histology (N=16,014) CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 21a. — Fig. 21a.
Distribution^a in Adolescents and Young Adults^b (Age 15-39 Years) of Primary Brain and Other CNS Tumors by Site (N=54,388), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

Fig. 21b. — Fig. 21b.
Distribution^a in Adolescents and Young Adults^b (Age 15-39 Years) of Primary Brain and Other CNS Tumors by Histology (N=54,388), CBTRUS Statistical Report: NPCR and SEER, 2009-2013.

See this image and copyright information in PMC

Similar articles

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.
Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS. Ostrom QT, et al. Neuro Oncol. 2015 Oct;17 Suppl 4(Suppl 4):iv1-iv62. doi: 10.1093/neuonc/nov189. Epub 2015 Oct 27. Neuro Oncol. 2015. PMID: 26511214 Free PMC article. No abstract available.
CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.
Ostrom QT, Price M, Ryan K, Edelson J, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS. Ostrom QT, et al. Neuro Oncol. 2022 Sep 6;24(Suppl 3):iii1-iii38. doi: 10.1093/neuonc/noac161. Neuro Oncol. 2022. PMID: 36066969 Free PMC article.
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.
Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. Ostrom QT, et al. Neuro Oncol. 2020 Oct 30;22(12 Suppl 2):iv1-iv96. doi: 10.1093/neuonc/noaa200. Neuro Oncol. 2020. PMID: 33123732 Free PMC article.
CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.
Dolecek TA, Propp JM, Stroup NE, Kruchko C. Dolecek TA, et al. Neuro Oncol. 2012 Nov;14 Suppl 5(Suppl 5):v1-49. doi: 10.1093/neuonc/nos218. Neuro Oncol. 2012. PMID: 23095881 Free PMC article. Review. No abstract available.
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015.
Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. Ostrom QT, et al. Neuro Oncol. 2018 Oct 1;20(suppl_4):iv1-iv86. doi: 10.1093/neuonc/noy131. Neuro Oncol. 2018. PMID: 30445539 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

Bioinformatic profiling identifies the glutaminase to be a potential novel cuproptosis-related biomarker for glioma.
Ouyang Z, Zhang H, Lin W, Su J, Wang X. Ouyang Z, et al. Front Cell Dev Biol. 2022 Sep 9;10:982439. doi: 10.3389/fcell.2022.982439. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36158220 Free PMC article.
Emerging Role of Neuron-Glia in Neurological Disorders: At a Glance.
Rahman MM, Islam MR, Yamin M, Islam MM, Sarker MT, Meem AFK, Akter A, Emran TB, Cavalu S, Sharma R. Rahman MM, et al. Oxid Med Cell Longev. 2022 Aug 22;2022:3201644. doi: 10.1155/2022/3201644. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36046684 Free PMC article. Review.
Mifepristone Repurposing in Treatment of High-Grade Gliomas.
Llaguno-Munive M, Vazquez-Lopez MI, Jurado R, Garcia-Lopez P. Llaguno-Munive M, et al. Front Oncol. 2021 Feb 18;11:606907. doi: 10.3389/fonc.2021.606907. eCollection 2021. Front Oncol. 2021. PMID: 33680961 Free PMC article. Review.
Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability.
Bu C, Hu S, Yu J, Li N, Gu J, Sheng Z, Yan Z, Bu X. Bu C, et al. Clin Transl Oncol. 2023 May;25(5):1378-1388. doi: 10.1007/s12094-022-03032-1. Epub 2022 Dec 9. Clin Transl Oncol. 2023. PMID: 36484954
Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas.
Li J, Zhang S, Chen S, Yuan Y, Zuo M, Li T, Wang Z, Liu Y. Li J, et al. Front Immunol. 2023 Feb 13;14:1021678. doi: 10.3389/fimmu.2023.1021678. eCollection 2023. Front Immunol. 2023. PMID: 36860853 Free PMC article.

See all "Cited by" articles

References

1. Centers for Disease Control and Prevention (CDC). National Program of Cancer Registries Cancer Surveillance System Rationale and Approach. 1999; http://www.cdc.gov/cancer/npcr/pdf/npcr_css.pdf.
1. Cancer Registries Amendment Act, 102nd Cong. § 5151992; http://www.gpo.gov/fdsys/pkg/STATUTE-106/pdf/STATUTE-106-Pg3372.pdf.
1. Benign Brain Tumor Cancer Registries Amendment Act, 107th Cong. § 2602002; http://www.gpo.gov/fdsys/pkg/PLAW-107publ260/pdf/PLAW-107publ260.pdf.
1. National Cancer Institute. Overview of the SEER Program. http://seer.cancer.gov/about/overview.html.
1. Wohrer A, Waldhor T, Heinzl H, et al. . The Austrian brain tumour registry: a cooperative way to establish a population-based brain tumour registry. J Neurooncol. 2009;95(3):401–411 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information